23 November 2023
Marlowe plc
Notice of Interim Results
Marlowe plc ("Marlowe" or the "Group"), the UK leader in business-critical services and software which assure regulatory compliance, will announce its unaudited half year results for the period ended 30 September 2023 on 28 November 2023 and host a virtual presentation for investors and equity analysts at 09:30 GMT.
A link to the event is here.
A video replay of the presentation will be available through the Marlowe website post-event.
For further information:
Marlowe plc | ||
Alex Dacre, Chief Executive | www.marloweplc.com | |
Adam Councell, Chief Financial Officer | Tel: +44 (0) 203 813 8498 | |
Benjamin Tucker, Investor Relations Manager | | |
| | |
Cavendish Securities plc (Nominated Adviser and Joint Broker) | ||
Ben Jeynes | Tel: +44 (0)20 7220 0500 | |
George Lawson | | |
| | |
Berenberg (Joint Broker) | ||
Ben Wright | Tel: +44 (0)20 3207 7800 | |
Mark Whitmore | | |
| | |
Stifel (Joint Broker) | ||
Matthew Blawat | Tel: +44 (0)20 7710 7688 | |
Francis North | | |
| | |
FTI Consulting | | |
Nick Hasell | Tel: +44 (0)20 3727 1340 | |
Alex Le May | | |
About Marlowe plc
Marlowe is a UK leader in business-critical services and software which assure regulatory compliance. The company was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated safety and compliance services and software. It is focused on compliance software, eLearning, health & safety, employment law & HR compliance, fire safety & security, water & air hygiene and occupational health services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides software to over 1 million users and services to over 25% of Britain's commercial premises. The Group provides customers with a single outsourced, nationwide, provider of a range of regulated compliance and safety solutions. Our customers can be found in office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.